(Total Views: 489)
Posted On: 05/22/2021 9:09:47 AM
Post# of 155592
You are totally wrong.
Nadar could have said nothing against investors reaching out which would be tacit approval to continue but instead he went out of his way to ask this not to be done.
He knows more about the situation than you.
Picking a fight is not the way to approval - let’s focus our energy getting approved the right way - it will be faster in the end.
By the way no BP is worried about leronlimab for Covid - there are no drugs gaining meaningful revenue in the immunological phase and EUA will only apply to COVID.
IMO. The Brazil trial should work else we will move to other indications for US approval.
IMO
Nadar could have said nothing against investors reaching out which would be tacit approval to continue but instead he went out of his way to ask this not to be done.
He knows more about the situation than you.
Picking a fight is not the way to approval - let’s focus our energy getting approved the right way - it will be faster in the end.
By the way no BP is worried about leronlimab for Covid - there are no drugs gaining meaningful revenue in the immunological phase and EUA will only apply to COVID.
IMO. The Brazil trial should work else we will move to other indications for US approval.
IMO
(3)
(0)
